The Health Research Authority (HRA) today announced it will go ahead with its plans to promote transparency in research after receiving comprehensive support for its proposals. The HRA plan contains robust and practical methods for addressing the problem of lack of transparency in clinical trial results via registration of clinical trials, publication, dissemination, access to data and informing research participants of study results. You can read more details on the HRA action plan in the Transparent Research report.

Janet Wisely, HRA Chief Executive said: “We have a duty to enable good quality ethical research, but we cannot achieve this by ourselves – it is incumbent on researchers, sponsors and funders to further the wider knowledge in their area of study, through the publication and dissemination of research findings, publishing all results, making data accessible to others and registering clinical trials. To do otherwise is a disservice to the public, the key partner in research whose interests we must work together to safeguard.”